First AI Antibody In Humans with Aulos' Aron Knickerbocker
Business Of Biotech
00:00
Peptidomimetics and Actinium-225 in Cancer Therapy
Exploring the use of peptidomimetics and actinium-225 in radiation therapy for cancer treatment, focusing on precision targeting of tumor cells while reducing toxicity. The chapter also delves into the formation of the company OLLOS, collaboration between ATP and Biologic Design, and the development of human monoclonal antibodies targeting IL-2 using AI-based antibody design. Insights on the potential role of creating antibodies against interleukin-2 to enhance tumor killing efficacy and mitigate immune suppression are discussed.
Transcript
Play full episode
